Loading
institutionsInstitution
Liverpool University Hospitals HPB centre (Aintree)
The North Western Hepatobiliary Centre at Aintree, serving Merseyside, Cheshire, North Wales and the Isle of Man; HPB surgeon Hassan Malik co-wrote the BSG cholangiocarcinoma guideline.
Also called: Liverpool University Hospitals NHS Foundation TrustNorth Western Hepatobiliary CentreAintree University Hospital
Overview
Liverpool University Hospitals is one of the trusts the National Pancreatic Cancer Audit identifies as an HPB specialist centre for England; Pancreatic Cancer UK lists its HPB team as covering Merseyside, Cheshire, the Isle of Man and North Wales. The liver surgery unit at Aintree (the North Western Hepatobiliary Centre) is on AMMF's list of centres with cholangiocarcinoma expertise. Non-surgical treatment is given with The Clatterbridge Cancer Centre.
Location
Liverpool, GB
Type
hospital · University of Liverpool
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#163 · 32 points (0 Newsweek + 0 NCI + 32 from 16 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-01.
Matched to Liverpool University Hospitals NHS Foundation Trust, including child institutions. 112 works · 647 citations · 68% open access · 5% clinical trials · 8% reviews.
Oncology works per year
182022
202023
282024
252025
212026
Most works
- Simon Neave Rogers8 works
- Robert Peter Jones8 works
- James N.R. Wyatt6 works
- Andrew Graeme Schache6 works
- Christopher Michael Halloran6 works
- Adrian Wayne Midgley6 works
- Declan Dunne6 works
- Zaed Z. R. Hamady5 works
- Andrew R. Levy5 works
- Joanne M Patterson5 works
Most cited
- HPB and liver surgery
- Specialist HPB MDT
- Cross-border care for North Wales
Bill Greenhalf
Reader, Molecular and Clinical Cancer Medicine, University of Liverpool
Familial pancreatic cancerHereditary pancreatitisBiomarkers
Liverpool molecular scientist behind the EUROPAC registry's laboratory work and the biomarker analyses of the ESPAC trial samples.
Chris Halloran
Professor of Pancreatic Surgery, University of Liverpool; Clinical Lead, EUROPAC
Pancreatic surgeryFamilial pancreatic cancer surveillanceSurgical trial methodology
Liverpool pancreatic surgeon who leads EUROPAC, the UK registry and surveillance programme for families with inherited pancreatic cancer risk and hereditary pancreatitis.
Daniel Palmer
Professor of Medical Oncology, University of Liverpool; Director, CRUK and NIHR Liverpool Experimental Cancer Medicine Centre; GIRFT joint clinical lead for pancreatic cancer
Pancreatic and hepatobiliary oncologyEarly-phase trialsAdjuvant chemotherapy
Liverpool medical oncologist, second author of ESPAC-4 and co-lead of ESPAC5, who directs the Liverpool Experimental Cancer Medicine Centre and leads the national GIRFT review of pancreatic cancer services.
Hassan Malik
Consultant Hepatobiliary Surgeon and Clinical Lead for Digestive Surgery, Liverpool University Hospitals (Aintree); Associate Professor, University of Liverpool
Hepatobiliary surgeryLiver resectionRetroperitoneal sarcoma
Liver surgeon at Aintree who co-wrote the BSG cholangiocarcinoma guideline and is a co-author of the UK-wide CAPBIL studies of gallbladder cancer surgery; a past president of the British Association of Surgical Oncology.
Paula Ghaneh
Professor of Surgery, Molecular and Clinical Cancer Medicine, University of Liverpool
Pancreatic surgeryAdjuvant and neoadjuvant trialsSurgical oncology
Liverpool pancreatic surgeon, chief investigator of ESPAC5, the UK trial of short-course neoadjuvant treatment for borderline resectable pancreatic cancer, and a co-author of ESPAC-3 and ESPAC-4.
real worldBritish Journal of Surgery 20260 citations
Management of incidental gallbladder cancer in the nationwide CAPBIL study
This is the UK baseline for the incidental cancer pathway: a re-resection rate well above the Dutch registry's 24 percent, with the same selection caveat. The abstract leaves out the histology, referral and timing detail; the full paper holds it.
real worldHPB 20260 citations
Surgical outcomes in gallbladder cancer: evidence from the UK nationwide CAPBIL study
The adjuvant finding sits uneasily beside BILCAP, on which NHS adjuvant capecitabine rests; in a mostly gallbladder population the benefit is not visible. ACTICCA-1 and ARTEMIDE-Biliary01 are the trials that can settle it.
Similar pages
- InstitutionDerriford Hospital, University Hospitals Plymouth
Shares EUROPAC, UK specialist HPB cancer centres, Hepatectomy (liver resection), Biliary tract cancer (all types) and the tags hpb, nhs, uk.
- InstitutionMorriston Hospital, Swansea
Shares EUROPAC, UK specialist HPB cancer centres, Hepatectomy (liver resection), Biliary tract cancer (all types) and the tags hpb, nhs, uk.
- InstitutionKing's College Hospital, London
Shares AMMF, the Cholangiocarcinoma Charity, UK specialist HPB cancer centres, Hepatectomy (liver resection), Biliary tract cancer (all types) and the tags hpb, nhs, uk.
- InstitutionUniversity Hospital of Wales, Cardiff
Shares AMMF, the Cholangiocarcinoma Charity, UK specialist HPB cancer centres, Hepatectomy (liver resection), Biliary tract cancer (all types) and the tags hpb, nhs, uk.
- InstitutionRoyal Infirmary of Edinburgh
Shares AMMF, the Cholangiocarcinoma Charity, UK specialist HPB cancer centres, Hepatectomy (liver resection), Biliary tract cancer (all types) and the tags hpb, nhs, uk.
- InstitutionBelfast Health and Social Care Trust HPB service
Shares AMMF, the Cholangiocarcinoma Charity, UK specialist HPB cancer centres, Hepatectomy (liver resection), Biliary tract cancer (all types) and the tags hpb, nhs, uk.
- InstitutionManchester Royal Infirmary HPB Unit
Shares AMMF, the Cholangiocarcinoma Charity, UK specialist HPB cancer centres, Hepatectomy (liver resection), Biliary tract cancer (all types) and the tags hpb, nhs, uk.
- InstitutionGlasgow Royal Infirmary
Shares EUROPAC, UK specialist HPB cancer centres, Hepatectomy (liver resection), Biliary tract cancer (all types) and the tags hpb, nhs, uk.